Anabolic steroids and cardiovascular morbidity.

Autor:	Windfeld-Mathiasen J; Klinisk Farmakologisk Afdeling, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital., Horwitz H; Klinisk Farmakologisk Afdeling, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.; Institut for Klinisk Medicin, Københavns Universitet., Biering-Sørensen T; Kardiologisk Afdeling, Københavns Universitetshospital - Herlev og Gentofte Hospital.; Biomedicinsk Institut, Københavns Universitet., Olsen FJ; Kardiologisk Afdeling, Københavns Universitetshospital - Herlev og Gentofte Hospital.; Biomedicinsk Institut, Københavns Universitet.; Kardiologisk Afdeling, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.
Jazyk:	dánština
Zdroj:	Ugeskrift for laeger [Ugeskr Laeger] 2024 Oct 14; Vol. 186 (42).
DOI:	10.61409/V04240260
Abstrakt:	Abuse of androgenic anabolic steroids (AAS) is associated with a range of cardiovascular side effects, summarized in this review. Apart from being linked to cardiovascular risk factors such as hypertension and dyslipidaemia, AAS abuse is associated with coronary atherosclerosis and imparts a pro-coagulative state, predisposing to thromboembolic disease. Finally, AAS abuse leads to left ventricular hypertrophy and dysfunction, which can ultimately result in heart failure. However, evidence is scarce, and further studies are needed to guide the optimal follow-up and treatment for these patients. (Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu